Trial reportInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2026
Energy dense nutritional supplements improve weight gain among malnourished adults with drug-sensitive pulmonary tuberculosis: An open-label randomized controlled trial in Faridabad, India.
Trial report in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Cost-effectiveness of in-kind nutritional support for impoverished persons with tuberculosis to reduce mortality and disengagement from care in India: a modelling study.BMJ global health · 2026Article
- From DOTS to DOST: a new framework for TB elimination in India.The Lancet regional health. Southeast Asia · 2026Review
- Reframing TB Care: A Perspective on Multimorbidity-Centered Care for People with TB.Tropical medicine and infectious disease · 2026Article
- Tuberculosis- learning about experience with nutritional supplementation (TB LENS): Perspectives on a nutritional supplementation for persons with TB and their household contacts.Global public health · 2025Article
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
objectivesUndernutrition affects nearly half of persons with tuberculosis (PWTB) in India and is a major determinant of poor treatment outcomes and impaired recovery. Randomized evidence on macronutrient supplementation in PWTB remains limited. We evaluated whether an energy-dense nutritional supplement (EDNS) could improve weight gain among undernourished adults with drug-sensitive pulmonary TB.
methodsWe conducted an open-label, two-arm randomized controlled trial in Faridabad, India (2020-2023). Adults with microbiologically confirmed pulmonary TB and mild to moderate undernutrition (BMI 14-18.5 kg/m²) were randomized to receive either EDNS plus standard dietary advice or standard dietary advice alone. Participants in the intervention arm received two sachets of EDNS daily for up to six months. Primary outcomes were ≥5% weight gain at 2 months and ≥10% at treatment completion. We conducted multivariable logistic regression to assess the impact of EDNS.
resultsAmong 335 participants randomized (171 intervention; 164 control), the intervention group had higher proportions achieving ≥5% weight gain at 2 months (53.9% vs 39.3%; P = 0.015) and ≥10% at six months (55.8% vs 41.0%; P = 0.023). After adjusting for covariates, EDNS improved odds of achieving these outcomes (month 2 adjusted odds ratio [aOR] 2.02 [95% CI: 1.25-3.30]; month 6 aOR 1.89 [95% CI: 1.13-3.18]). Acceptability and adherence were high. Gastrointestinal symptoms were more frequent but did not require treatment modification.
conclusionEDNS significantly improved weight gain among undernourished PWTB and may represent a practical, scalable approach to complement existing food basket and cash transfer strategies to aid nutritional recovery during TB treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.